Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 12/20 | 0.48 |
| ▸ | POLB | P06746 | 8/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 10/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | LMNA | P02545 | 7/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.45 |
| ▸ | NPC1 | O15118 | 5/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 5/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | HTT | P42858 | 7/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nifurpirinol SCHEMBL1650816 | 1.00 | KMT2A (0.48) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Nifurpirinol SCHEMBL28198718 | 0.80 | MITF (0.45) | KMT2APOLBTDP1MEN1ALDH1A1 | |
| Nifurquinazol SCHEMBL28198699 | 0.79 | KMT2A (0.44) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL28433359 | 0.75 | KMT2A (0.61) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL28433360 | 0.75 | KMT2A (0.61) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL31649237 | 0.74 | NPC1 (0.58) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Acetic Acid SCHEMBL4458658 | 0.71 | KMT2A (0.56) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Acetic Acid SCHEMBL4458652 | 0.71 | KMT2A (0.56) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| Acetic Acid SCHEMBL4458660 | 0.71 | KMT2A (0.56) | KMT2APOLBL3MBTL1TDP1MEN1 | |
| SCHEMBL10643025 | 0.70 | KMT2A (0.55) | KMT2APOLBL3MBTL1TDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1734 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250099557-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| EP-4374848-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | Shanghai Bao Pharmaceuticals Co., Ltd. (CN) | 2024-05-29 | — | — | EP | claimed |
| US-10449247-B2 | Compositions and methods for enhancing immune response | AVIVAGEN INC. (CA) | 2019-10-22 | — | — | US | claimed |
| EP-2953624-B1 | METHODS OF TREATING MICROBIAL INFECTIONS, INCLUDING MASTITIS | LUODA PHARMA LTD (IE) | 2019-08-21 | — | — | EP | claimed |
| US-20190008993-A1 | Compositions for Treating Biofilms and Methods for Using Same | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2019-01-10 | — | — | US | claimed |
| US-9884136-B2 | Compositions for treating biofilms and methods for using same | PLUROGEN THERAPEUTICS, INC. (US) | 2018-02-06 | — | — | US | claimed |
| US-20170216480-A1 | COMPOSITIONS FOR TREATING BIOFILMS AND METHODS FOR USING SAME | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2017-08-03 | — | — | US | claimed |
| EP-3170396-A1 | COMPOSITIONS FOR TREATING BIOFILMS AND METHODS FOR USING SAME | Plurogen Therapeutics, Inc. (US) | 2017-05-24 | — | — | EP | claimed |
| US-9603966-B2 | Compositions for treating biofilms and methods for using same | PLUROGEN THERAPEUTICS, INC. (US) | 2017-03-28 | — | — | US | claimed |
| US-20160151533-A1 | COMPOSITIONS FOR TREATING BIOFILMS AND METHODS FOR USING SAME | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2016-06-02 | — | — | US | claimed |
| WO-2000061549-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000061541-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000061537-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0786999-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1999-01-20 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| US-5635540-A | STABLE MIXTURE OF ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER AND WATER AS CARRIER FOR ANTIBIOTICS, FUNGICIDES OR ANESTHETICS, FOR TREATING SKIN DISEASES, BURNS, WOUNDS | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1997-06-03 | — | — | US | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| US-4046085-A | Method and apparatus for treating waste material in a counter-current incinerator | NICHOLS ENGINEERING & RESEARCH CORPORATION (US) | 1977-09-06 | — | — | US | claimed |